Bioprinting of oral tissues

Bioprinting of oral tissues represents a rapidly advancing frontier in regenerative dentistry and craniofacial tissue engineering. This approach leverages precise, layer-by-layer deposition of cell-laden bioinks to recreate the complex architecture, cellular heterogeneity, and functional characteristics of oral tissues, which include soft tissues (gingiva, oral mucosa), mineralized tissues (alveolar bone, dentin), and composite structures (periodontal ligament, dental pulp).Bioprinting Targets and Tissue ComplexityThe oral cavity presents a range of bioprinting targets each with unique structural and biological challenges. Gingival and mucosal tissues require constructs mimicking stratified squamous epithelium and connective tissue compartments, often achieved through co-culture of keratinocytes and fibroblasts embedded within hydrogels [1]. Hard tissues such as alveolar bone demand scaffolds with osteoconductive properties and mechanical strength, frequently realized through composite bioinks incorporating natural polymers and ceramics like hydroxyapatite [1][2]. The periodontal ligament (PDL) is a fibrous interface with spatial gradients of attachment to cementum and bone, requiring bioprinting strategies capable of producing anisotropic, multi-phasic constructs [1]. Dental pulp-dentin regeneration focuses on recapitulating the pulp’s vascularized, innervated soft tissue core and its mineralized dentin boundary, necessitating bioinks supporting stem cell differentiation and angiogenesis [3].Bioprinting Techniques and AdvancesExtrusion-based bioprinting is currently the predominant method for oral tissue engineering due to its versatility in printing high-viscosity bioinks and multilayered cellular arrangements [4][5]. Inkjet and laser-assisted bioprinting offer superior resolution but are limited by ink viscosity and complexity, respectively. Emerging stereolithographic approaches provide high precision for mineralized structures, particularly useful for dental hard tissues [1]. The integration of multimaterial and multimodal bioprinting is enabling the fabrication of heterogeneous constructs with controlled spatial distribution of cells and matrix, critical for functional tissue mimicry [5].Bioink Formulations and Cell ChoiceNatural polymers such as collagen, gelatin methacryloyl (GelMA), and hyaluronic acid remain central to bioink development due to their biocompatibility and capacity for cell adhesion and proliferation [4][6]. Synthetic polymers like polycaprolactone (PCL) add mechanical reinforcement and control degradation rates suited for alveolar bone scaffolds [7]. Composite bioinks combining these components with ceramics enable osteoinductivity necessary for mineralized tissue regeneration [1]. Cellular components include mesenchymal stem cells (MSCs), dental pulp stem cells (DPSCs), periodontal ligament stem cells (PDLSCs), and induced pluripotent stem cells (iPSCs), offering the crucial ability to differentiate into target oral tissue phenotypes and support vascularization [3][8].Recent Progress and Application ExamplesBioprinted gingival equivalents with multilayer epithelial architecture and fibroblast-laden connective matrix have demonstrated promising histological and functional characteristics comparable to native tissue [1][9]. Multiphase constructs simulating the periodontal complex—replicating cementum, PDL, and alveolar bone—have been successfully created using gradient bioink deposition and spatially controlled cell placement [1]. Alveolar bone constructs biofabricated with osteogenic stem cells and ceramic-enriched scaffolds show in vivo bone matrix deposition and early vascularization, providing a foundation for future implant integration [2]. Efforts in pulp-dentin complex printing have produced vascularized, stem cell-laden constructs that promote odontogenic differentiation, though full tooth regeneration remains a significant hurdle [1][3]. Additionally, bioprinted oral mucosa is utilized as grafts for oral cancer reconstruction and as in vitro models for drug screening [9].Challenges and Future DirectionsThe main technical obstacle across all oral tissues is establishing a functional and stable vascular network within the bioprinted constructs to support viability post-implantation. Strategies involving co-printing endothelial cells, incorporation of angiogenic factors, or sacrificial bioinks to create perfusable channels are under active investigation [3][5][8]. Innervation, critical for tissues such as dental pulp and tongue, remains insufficiently addressed, with advances in neural tissue biofabrication needed to restore sensory functions [9]. The spatial complexity and multi-tissue interfaces inherent to oral structures, such as the cementum-PDL-bone continuum, demand enhanced biofabrication techniques capable of precise gradient control and biomimetic signaling. Clinically, regulatory pathways, cell sourcing, and scalable manufacturing represent translational bottlenecks requiring multidisciplinary collaboration [3][5].SummaryIn summary, bioprinting technologies have matured to a stage where the fabrication of anatomically relevant and biologically functional oral tissues is becoming increasingly feasible. The convergence of advanced bioprinting modalities, bioink engineering, and stem cell biology is enabling not only therapeutic constructs for regenerative dentistry but also powerful in vitro models for research and drug development. Continued progress in vascularization, innervation, and heterotypic tissue interface recreation is vital for clinical translation. This dynamic field promises transformative impact on patient-specific oral tissue regeneration and personalized medicine approaches in dentistry [1][3][5][6][8][9].